During the analysis of the degree of correlation between NIS expression and clinical parameters, we did not find a statistical relationship with TNM stages, age, mitotic or proliferative activity of the tumor (Ki-67), etc. Statistically significant was the correlation with the level of residual cancer burden (RCB), assessed after neoadjuvant chemotherapy and mastectomy [33]. The gene discussed is SLC5A5; the disease is cancer.